Easterly Government Properties, Inc. (NYSE:DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government, announced today that it has been awarded the lease for a 65,810 square foot Food and Drug Administration (FDA) laboratory in Alameda, CA.

The FDA is the federal agency responsible for protecting and promoting the health and safety of the American public by assuring the safety, efficacy and security of human and veterinary drugs, our nation’s food supply, biological products, medical devices, and other products including cosmetics. Given its mission, the FDA plays a significant role in our nation’s counterterrorism capability by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats.

“We are pleased, as a partner to the U.S. Government, to have been awarded this 20-year lease for the FDA laboratory. Bringing our years of experience to build mission critical facilities from the ground up will further enhance our high quality portfolio" said Michael Ibe, Vice Chairman and EVP of Development and Acquisitions of Easterly Government Properties, Inc.

The FDA is a science-based, science-led organization, the success of which often depends on the ability of the agency's laboratories to quickly and accurately analyze samples and report results for regulatory action. The agency operates 13 high throughput field laboratories, located strategically across the country. The FDA - Alameda laboratory will become the newest laboratory in the FDA’s portfolio and, upon completion, will be leased to the General Services Administration (GSA) for a 20-year term.

“The internal team at Easterly, led by Michael Ibe, has significant experience in the development of GSA-leased properties, having completed 20 projects since 1994. Our thorough understanding of the U.S. Government’s procurement processes and standards, our longstanding relationships with the GSA, and our differentiated capabilities enabled Easterly to compete successfully for this lease award” said Meghan Baivier, Chief Financial and Operating Officer of Easterly Government Properties, Inc. “FDA - Alameda, which meets Easterly’s strict underwriting criteria, is accretive to the company’s proven strategy of growing an outstanding portfolio of mission-critical buildings leased to the U.S. Government, one of the strongest credit tenants globally.”

About Easterly Government Properties, Inc.

Easterly Government Properties, Inc. (NYSE:DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com.

This press release contains forward-looking statements within the meaning of federal securities laws and regulations. These forward-looking statements are identified by their use of terms and phrases such as “believe,” “expect,” “intend,” “project,” “anticipate,” “position,” and other similar terms and phrases, including references to assumptions and forecasts of future results. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. These risks include, but are not limited to those risks and uncertainties associated with our business described from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K filed on March 2, 2016. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that the expectations will be attained or that any deviation will not be material. All information in this release is as of the date of this release, and we undertake no obligation to update any forward-looking statement to conform the statement to actual results or changes in our expectations.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160628005139/en/